Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Academic Medical Research Institute
mi
from
Los Angeles, CA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Academic Medical Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Ronald Reagan Medical Center, Department of Pharmaceutical Services, Drug Information Center
mi
from
Los Angeles, CA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Ronald Reagan Medical Center, Department of Pharmaceutical Services, Drug Information Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Tower Nephrology Medical Group
mi
from
Los Angeles, CA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Tower Nephrology Medical Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Kidney Research Center
mi
from
Lynwood, CA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Kidney Research Center
mi
from
Lynwood, CA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Valley Renal Medical Group
mi
from
Northridge, CA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Valley Renal Medical Group
mi
from
Northridge, CA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Ontario Dialysis, Inc.
mi
from
Ontario, CA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Ontario Dialysis, Inc.
mi
from
Ontario, CA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Apex Research of Riverside
mi
from
Riverside, CA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Apex Research of Riverside
mi
from
Riverside, CA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Capital Nephrology Medical Group
mi
from
Sacramento, CA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Capital Nephrology Medical Group
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
La Jolla Clinical Research, Inc.
mi
from
San Diego, CA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
La Jolla Clinical Research, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
American Institute of Research
mi
from
Whittier, CA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
American Institute of Research
mi
from
Whittier, CA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
South Florida Nephrology
mi
from
Coral Springs, FL
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
South Florida Nephrology
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Pines Clinical Research Inc.
mi
from
Hollywood, FL
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Pines Clinical Research Inc.
mi
from
Hollywood, FL
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Genesis Clinical Research Corporation
mi
from
Tampa, FL
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Genesis Clinical Research Corporation
mi
from
Tampa, FL
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Atekha Nephrology Clinic LLC
mi
from
Statesboro, GA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Atekha Nephrology Clinic LLC
mi
from
Statesboro, GA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Four Rivers Clinical Research, Incorporated
mi
from
Paducah, KY
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Four Rivers Clinical Research, Incorporated
mi
from
Paducah, KY
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Northwest Louisana Nephrology
mi
from
Shreveport, LA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Northwest Louisana Nephrology
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Germantown Dialysis
mi
from
Germantown, MD
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Germantown Dialysis
mi
from
Germantown, MD
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Creighton University
mi
from
Omaha, NE
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Kidney Specialists of Southern Nevada
mi
from
Las Vegas, NV
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Kidney Specialists of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Seacoast Kidney and Hypertension Specialist, PLLC
mi
from
Portsmouth, NH
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Seacoast Kidney and Hypertension Specialist, PLLC
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Renal Medicine Associates
mi
from
Albuquerque, NM
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Renal Medicine Associates
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
New York Hospital Queens
mi
from
Brooklyn, NY
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
New York Hospital Queens
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Metrolina Nephrology Associates, PA
mi
from
Charlotte, NC
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Metrolina Nephrology Associates, PA
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Boice-Willis Clinic
mi
from
Rocky Mount, NC
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Boice-Willis Clinic
mi
from
Rocky Mount, NC
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Southeastern Dialysis Center
mi
from
Wilmington, NC
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Southeastern Dialysis Center
mi
from
Wilmington, NC
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Northeast Clinical Research Centers, Inc.
mi
from
Bethlehem, PA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Northeast Clinical Research Centers, Inc.
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Delaware Valley Nephrology and Hypertension Associates, PC
mi
from
Philadelphia, PA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Delaware Valley Nephrology and Hypertension Associates, PC
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Rhode Island Hospital
mi
from
Providence, RI
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
SC Nephrology & Hypertension Center, Inc.
mi
from
Orangeberg, SC
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
SC Nephrology & Hypertension Center, Inc.
mi
from
Orangeberg, SC
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Palmetto Nephrology Pa
mi
from
Orangeburg, SC
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Palmetto Nephrology Pa
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Knoxville Kidney Center PLLC
mi
from
Knoxville, TN
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Knoxville Kidney Center PLLC
mi
from
Knoxville, TN
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Research Management, Inc.
mi
from
Austin, TX
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Research Management, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Nephrology, P.A.
mi
from
Houston, TX
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Nephrology, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Clinical Trial Network
mi
from
Houston, TX
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Renal Associates, PA
mi
from
San Antonio, TX
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Renal Associates, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Southern Utah Kidney and Hypertension Center
mi
from
St. George, UT
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Southern Utah Kidney and Hypertension Center
mi
from
St. George, UT
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
Mendez Center for CLinical Research, LLC
mi
from
Alexandria, VA
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
Mendez Center for CLinical Research, LLC
mi
from
Alexandria, VA
Click here to add this to my saved trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated:  9/17/2013
West Virginia University Hospitals and Clinic
mi
from
Morgantown, WV
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of HX575 Epoetin Alfa vs. US Licensed Epoetin Alfa (Epogen®/Procrit®) in the Treatment of Anemia Associated With Chronic Kidney Disease
Status: Enrolling
Updated: 9/17/2013
West Virginia University Hospitals and Clinic
mi
from
Morgantown, WV
Click here to add this to my saved trials
An Electronic Alert System for In-Hospital Acute Kidney Injury
An Electronic Alert System for In-Hospital Acute Kidney Injury: A Randomized, Controlled Trial
Status: Enrolling
Updated:  9/17/2013
Hospital of the University of Pennsylvania
mi
from
Phiadelphia, PA
An Electronic Alert System for In-Hospital Acute Kidney Injury
An Electronic Alert System for In-Hospital Acute Kidney Injury: A Randomized, Controlled Trial
Status: Enrolling
Updated: 9/17/2013
Hospital of the University of Pennsylvania
mi
from
Phiadelphia, PA
Click here to add this to my saved trials
The Pharmacokinetics of MK-5172 and MK-8742 in Participants With Renal Insufficiency (MK-5172-050-00)
An Open-Label Study to Investigate the Pharmacokinetics of MK-5172 and MK-8742 in Subjects With Renal Insufficiency
Status: Enrolling
Updated:  10/10/2013
Clinical Research Facility
mi
from
Hialeah, FL
The Pharmacokinetics of MK-5172 and MK-8742 in Participants With Renal Insufficiency (MK-5172-050-00)
An Open-Label Study to Investigate the Pharmacokinetics of MK-5172 and MK-8742 in Subjects With Renal Insufficiency
Status: Enrolling
Updated: 10/10/2013
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
The Pharmacokinetics of MK-5172 and MK-8742 in Participants With Renal Insufficiency (MK-5172-050-00)
An Open-Label Study to Investigate the Pharmacokinetics of MK-5172 and MK-8742 in Subjects With Renal Insufficiency
Status: Enrolling
Updated:  10/10/2013
Clinical Research Facility
mi
from
Orlando, FL
The Pharmacokinetics of MK-5172 and MK-8742 in Participants With Renal Insufficiency (MK-5172-050-00)
An Open-Label Study to Investigate the Pharmacokinetics of MK-5172 and MK-8742 in Subjects With Renal Insufficiency
Status: Enrolling
Updated: 10/10/2013
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Milrinone Pharmacokinetics and Acute Kidney Injury
USE OF ACUTE KIDNEY INJURY BIOMARKERS TO PREDICT IMPAIRED MILRINONE PHARMACOKINETICS IN CHILDREN FOLLOWING CARDIAC SURGERY
Status: Enrolling
Updated:  10/17/2013
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Milrinone Pharmacokinetics and Acute Kidney Injury
USE OF ACUTE KIDNEY INJURY BIOMARKERS TO PREDICT IMPAIRED MILRINONE PHARMACOKINETICS IN CHILDREN FOLLOWING CARDIAC SURGERY
Status: Enrolling
Updated: 10/17/2013
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Predictors of Respiratory Failure Following Extubation in the SICU
Predictors of Respiratory Failure Following Extubation in Teh Surgical Intensive Care Unit (SICU)
Status: Enrolling
Updated:  10/17/2013
Massachusetts General Hospital
mi
from
Boston, MA
Predictors of Respiratory Failure Following Extubation in the SICU
Predictors of Respiratory Failure Following Extubation in Teh Surgical Intensive Care Unit (SICU)
Status: Enrolling
Updated: 10/17/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability
The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability
Status: Enrolling
Updated:  10/29/2013
Chicopee Dialysis Center
mi
from
Chicopee, MA
The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability
The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability
Status: Enrolling
Updated: 10/29/2013
Chicopee Dialysis Center
mi
from
Chicopee, MA
Click here to add this to my saved trials
Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease
A Phase 1, Open-label, Sequential Crossover Study to Evaluate the Effect of Hemodialysis on the Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease
Status: Enrolling
Updated:  11/1/2013
Clinical Research Facility
mi
from
Minneapolis, MN
Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease
A Phase 1, Open-label, Sequential Crossover Study to Evaluate the Effect of Hemodialysis on the Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease
Status: Enrolling
Updated: 11/1/2013
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease
Streptococcus Pneumoniae Colonization and Immunogenicity of 13-valent Conjugate Pneumococcal Vaccine in Patients 50 Years or Older With End Stage Renal Disease on Dialysis.
Status: Enrolling
Updated:  11/4/2013
Sparrow Dialysis at Saint Lawrence Campus
mi
from
Lansing, MI
Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease
Streptococcus Pneumoniae Colonization and Immunogenicity of 13-valent Conjugate Pneumococcal Vaccine in Patients 50 Years or Older With End Stage Renal Disease on Dialysis.
Status: Enrolling
Updated: 11/4/2013
Sparrow Dialysis at Saint Lawrence Campus
mi
from
Lansing, MI
Click here to add this to my saved trials
Study Assessing the Behavior of Delayed-Release Metformin in Subjects With Kidney Dysfunction
A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction
Status: Enrolling
Updated:  11/12/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Study Assessing the Behavior of Delayed-Release Metformin in Subjects With Kidney Dysfunction
A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction
Status: Enrolling
Updated: 11/12/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Study Assessing the Behavior of Delayed-Release Metformin in Subjects With Kidney Dysfunction
A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction
Status: Enrolling
Updated:  11/12/2013
Compass Research LLC
mi
from
Orlando, FL
Study Assessing the Behavior of Delayed-Release Metformin in Subjects With Kidney Dysfunction
A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction
Status: Enrolling
Updated: 11/12/2013
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Study Assessing the Behavior of Delayed-Release Metformin in Subjects With Kidney Dysfunction
A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction
Status: Enrolling
Updated:  11/12/2013
Prgressive Medical Research
mi
from
Port Orange, FL
Study Assessing the Behavior of Delayed-Release Metformin in Subjects With Kidney Dysfunction
A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction
Status: Enrolling
Updated: 11/12/2013
Prgressive Medical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
Study Assessing the Behavior of Delayed-Release Metformin in Subjects With Kidney Dysfunction
A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction
Status: Enrolling
Updated:  11/12/2013
Louisville Metabolic and Atherosclerosis Research Center
mi
from
Louisville, KY
Study Assessing the Behavior of Delayed-Release Metformin in Subjects With Kidney Dysfunction
A Randomized, Crossover Study Assessing the Single Dose Pharmacokinetics of Delayed-Release Metformin in Subjects With Renal Dysfunction
Status: Enrolling
Updated: 11/12/2013
Louisville Metabolic and Atherosclerosis Research Center
mi
from
Louisville, KY
Click here to add this to my saved trials